Company intelligence / Profile preview
Avistone Biotechnology Co., Ltd.
Wangjing Science and Technology Park Chaoyang District Lizezhong Road area HQ/R&D, Beijing, Chinaen.avistonebio.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Avistone Biotechnology is an active Chinese biotechnology company specializing in precision oncology therapeutics primarily targeting genetically defined subsets of non-small cell lung cancer and other solid tumors.
- Therapeutic areas
- Oncology
- Modalities
- Small molecule inhibitors (e.g. tyrosine kinase inhibitors)Targeted therapies in oncology
- Industry
- Biotech
02
Drug pipeline
10 assets9 more assets in the full pipeline.
03
Partnerships
Vivo CapitalBain Capital Life SciencesPrimavera CapitalIDG CapitalCathay CapitalSDIC CS CapitalYanchuang Capital
Beyond the preview
Go deeper on Avistone Biotechnology Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Avistone Biotechnology Co., Ltd..